Refer a Patient. Keep the Physician in Control.
CancerCareE helps physicians review potential international treatment pathways, relevant clinical trials, and access conditions — without replacing clinical judgment or the patient's own decision-making.
A referral is a request for evaluation, not a confirmation of eligibility, admission, or treatment availability. You remain the treating physician. Medical decisions remain with you and your patient.
Quick Answer
For patients who have exhausted standard local pathways, or for whom a second opinion may help, CancerCareE organizes publicly available information about potential international treatment pathways, clinical trials, and access conditions. The referral process begins with a minimal initial request — no full medical records, no identifiable patient data — and proceeds only if the clinical question suggests that further review may be useful.
A Reality Check
Common assumption: "A referral to an international platform means the patient will be admitted, matched to a trial, or moved to treatment abroad."
Reality: A referral is a request for evaluation — not a confirmation of eligibility, admission, or treatment availability. CancerCareE organizes information and facilitates introductions when there is a clear clinical rationale and patient willingness. All access decisions remain with the receiving institution and the treating physician.
What a Referral Is — and What It Is Not
A referral IS
- A structured request for evaluation of possible next-step options
- An information-gathering step with minimal initial data
- A starting point for discussion with the patient
- Physician-led and patient-consented
A referral IS NOT
- A guarantee of eligibility or admission
- A confirmation of treatment availability
- A medical second opinion or tumor board decision
- A transfer of clinical responsibility
When a Referral May Be Useful
Four clinical situations where a structured review of international options may help a physician and their patient.
Standard Options Have Been Exhausted
The patient has progressed after prior lines of therapy, and the physician wants to review potential next-step options that may exist in other jurisdictions.
Clinical Trial Review Is Needed
The physician wants to identify trials in other countries or centers — without treating the existence of a study as equivalent to a patient's eligibility or admission.
Additional Specialist Input May Help
The physician wants to determine whether additional specialist input could help clarify unanswered clinical questions in a complex case.
International Access Is Under Discussion
The patient has expressed willingness to explore treatment abroad, and the physician wants to understand preliminary admission conditions, general cost categories, and practical feasibility.
Important: A referral is a request for evaluation — not a confirmation of eligibility, admission, or treatment availability.
A Three-Stage Process — Not a Long Form
Many referral forms request extensive information before the physician knows whether the service is even appropriate. We split the process into three stages, so that information is requested only when it is genuinely needed.
Initial Referral
A minimal request to understand the clinical question and the type of review being requested. No full medical records, no identifiable patient data.
- Physician professional details and contact channel
- Specialty and country of practice
- Request type: pathway review, trial, specialist input, or access feasibility
- Cancer type and general treatment context — only what is needed to start
- Confirmation of authorization and patient awareness
Case Preparation
Only if the initial request suggests a meaningful review may be possible, the physician is guided on what additional context would be useful for the specific question.
- Specific documents relevant to the question (not a full record dump)
- Shared through a channel the physician chooses — email or direct message
- Clear scope of what will be reviewed and what will not
- No full medical records stored on this website
Pathway Review
A structured summary of identified options, their sources, limitations, and the open questions that would need to be answered before any referral proceeds.
- Identified options with sources
- Preliminary criteria and information gaps
- Access status, with date of last verification where available
- Cost categories where reliable information exists (not binding quotes)
- Unresolved questions and suggested next step
Expected Output of a Pathway Review
A common weakness of referral pages is asking physicians to send information without clarifying what they will receive in return. The following describes what an output may contain — always subject to the services currently available.
Options Report
Identified pathways, their sources, their limitations, and the open questions that remain.
Trial Summary
Study identifiers, registry status, relevant criteria, and whether the site has been contacted — where applicable.
Access Feasibility Summary
General cost categories, expected timelines where documented, admission requirements, and items still unconfirmed.
Open Questions
Explicit identification of what is still unknown or unverified — so that no decision is made on assumptions.
Five Commitments
Physician-led decisions
Clinical decisions remain with the treating physician and the patient.
Informed patient consent
Any introduction or sharing of information proceeds only with the patient's awareness and consent.
Evidence-linked information
Scientific and regulatory claims are linked to publicly verifiable sources.
Transparent access conditions
Unknown or unverified status is not hidden — it is clearly flagged.
Financial transparency
Any financial relationship relevant to an introduction is disclosed clearly. See Financial Transparency.
Clinical Need → Required Capability → Potential Access Paths
A general framework for evaluating whether an international pathway is worth exploring further. This is illustrative and does not represent specific recommendations.
| Clinical Need | Required Capability | Potential Access Paths |
|---|---|---|
| Patient has exhausted standard local treatment lines | Availability of investigational or regionally approved therapies | Public trial registries; partner institutions; documented access requirements |
| Rare molecular target with limited published data | Site-specific experience and protocol availability | Registry-based trial search; direct site inquiry; peer literature review |
| Therapy approved in one jurisdiction but not another | Regulatory status and cross-border access conditions | Regulatory authority records; partner institution confirmation |
| Patient requires treatment coordination abroad | Feasibility of travel, documentation, and continuity of care | Partner institutions; documented logistics and repatriation planning |
Frequently Asked Questions
Is a referral the same as confirming a patient's eligibility?
No. A referral is a request for evaluation. Eligibility, admission, and treatment availability are determined by the receiving institution after a full review — not by CancerCareE, and not by the referral itself.
What information is needed to start a referral?
Only what is needed to understand the clinical question: professional details of the referring physician, the type of review being requested, the cancer type, and the general treatment context. No full medical records or identifiable patient data are requested through this website.
Do I need to prepare the full patient file before starting?
No. The initial step is intentionally minimal. Preparation of any additional context is requested only if the initial review suggests it would be useful — and only through a channel the physician chooses.
What happens if the review suggests no meaningful next step?
If the clinical question does not correspond to a realistic review at this time, CancerCareE will say so — including reasons and open questions. A referral does not commit the physician or patient to any further step.
Does CancerCareE contact the patient directly?
No. Communication is physician-to-CancerCareE at the initial stage. Any further coordination is discussed with the referring physician first, and contact with the patient occurs only with the physician's awareness and the patient's consent.
Is there any cost to the referring physician?
No. The referral process and initial review are free of charge to referring physicians. CancerCareE may receive a fixed referral fee from partner institutions after a patient is introduced — details are published on the Financial Transparency page.
What is CancerCareE's role in the referral?
CancerCareE organizes publicly available evidence and access information into a structured format, and facilitates introductions to partner institutions where a pathway appears worth exploring. We are not a healthcare provider and do not make clinical decisions.
Start a Referral Request
This is the initial step. It is intentionally minimal — no full medical records and no identifiable patient data. When you click send, your default email client or WhatsApp will open with the information you provided, so you can review it before sending. Nothing is stored on this website.
Ready to Explore a Patient's Options?
Start with a brief referral request. We will use the information provided to determine the appropriate next step, subject to the services currently available.
Explore Related Information
Sources and Further Reading
- U.S. National Library of Medicine — ClinicalTrials.gov. Public registry of clinical studies. Available at: clinicaltrials.gov
- World Health Organization — International Clinical Trials Registry Platform (ICTRP). Available at: who.int/clinical-trials-registry-platform
- U.S. Food and Drug Administration — Oncology guidance documents. Available at: fda.gov
- European Medicines Agency — Oncology product information. Available at: ema.europa.eu
- National Medical Products Administration (NMPA), China — Regulatory information. Available at: nmpa.gov.cn
- PubMed — Biomedical literature database. Available at: pubmed.ncbi.nlm.nih.gov